Skip to main content

Table 2 Demographics and baseline characteristics by treatment group

From: Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial

Category

Hydros n = 32

Hydros TA n = 34

Synvisc-One n = 32

Age in years, mean (SD)

59 (12)

61 (11)

59 (12)

Gender, n (%)

   

  Male

12 (38)

14 (41)

16 (50)

  Female

20 (63)

20 (59)

16 (50)

Race, n (%)

   

  Caucasian

23 (72)

28 (82)

23 (72)

  Non-Caucasian

9 (28)

6 (18)

9 (28)

Body Mass Index in kg/m 2 , mean (SD)

29.8 (4.1)

29.0 (4.1)

29.0 (3.8)

  Kellgren-Lawrence Grade for Treatment Knee, n (%)

   

  Grade 2

18 (56)

22 (65)

18 (56)

  Grade 3

14 (44)

12 (35)

14 (44)

  Pre-Treatment WOMAC score in mm, mean (SD)

   

  Treatment Knee

68 (9)

69 (11)

66 (12)

  Non-treatment Knee

13 (8)

12 (9)

12 (8)

Duration of Symptoms - Pre-Treatment in Treatment Knee in months, mean (SD)

64 (59)

74 (80)

69 (56)

  1. Abbreviations: WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index.